Novo Nordisk stock trades at 4-year-low on the back of disappointing Alzheimer’s trial Nick Lichtenberg Fortune 3 0 25.11.2025 The stock of the Wegovy and Ozempic maker is down nearly 50% year to date.© Fortune visit website